After considering the feedback from consultation, the Appraisal Committee has prepared a Final Appraisal Determination (FAD) on Dapagliflozin in combination therapy for treating type 2 diabetes [ID427] and submitted it to the Institute (NICE)
Diabetes News Service
After considering the feedback from consultation, the Appraisal Committee has prepared a Final Appraisal Determination (FAD) on Dapagliflozin in combination therapy for treating type 2 diabetes [ID427] and submitted it to the Institute (NICE)
For iPhone and iPad | For Android devices
For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com
Website by Wired up Wales